Corcept Therapeutics

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$17Mgeneral payments (2019-2025)
$193Kresearch payments (2019-2025)
31,747clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.4M
2020 $804K
2021 $1.5M
2022 $1.5M
2023 $2.1M
2024 $3.8M
2025 $5.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Endocrinology, Diabetes & Metabolism $9.6M
Family $1.5M
Internal Medicine $1.2M
Family Medicine $1.1M
Medical $542K
Physician Assistant $374K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Hanford Yau Orlando, FL Endocrinology, Diabetes & Metabolism $486,756.80
Kevin Pantalone Cleveland, OH Endocrinology, Diabetes & Metabolism $459,087.59
Alison Gracom Irvine, CA Medical $403,453.47
Bradley Eilerman Florence, KY Endocrinology, Diabetes & Metabolism $393,402.70
Eduardo Luna Edinburg, TX Endocrinology, Diabetes & Metabolism $346,752.34
Elena Christofides Columbus, OH Endocrinology, Diabetes & Metabolism $327,601.21
Honey East Jackson, MS Endocrinology, Diabetes & Metabolism $319,303.07
Robin Anderson Portage, IN Family $319,145.44
Christopher Lucci Rockport, TX Public Health & General Preventive Medicine $315,469.00
David Brown Rockville, MD Endocrinology, Diabetes & Metabolism $280,251.32

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.